Microgravity drug research is expanding from ISS crystal studies to commercial manufacturing efforts. New experiments and a Varda-United Therapeutics collaboration target improved drug stability, delivery and production.
An ISS National Laboratory-sponsored project will send six extremophile microbes from Antarctica and Chile to the space station for about six months of exposure. Researchers will analyze genetic, structural, and protein-level changes after return to Earth.
Thrive Capital has raised more than $10 billion in its largest fund ever. The fundraising was heavily oversubscribed and the cash influx was double the size of its last fund.
HEALWELL AI and WELL Health have launched WELLTRUST, a consent-first platform that uses AI to identify and recruit patients for clinical trials across WELL's network of 240+ clinics and 43,000 healthcare providers in the US and Canada.
